Targeting ubiquitination for cancer therapies.

Targeting ubiquitination for cancer therapies.

Item
http://www.wikidata.org/entity/Q37158445
Cell division cycle 34 is highly expressed in hepatitis C virus-positive hepatocellular carcinoma with favorable phenotypes.Anti-infective Activity of 2-Cyano-3-Acrylamide Inhibitors with Improved Drug-Like Properties against Two Intracellular Pathogens.Highly Multiplexed Quantitative Mass Spectrometry Analysis of Ubiquitylomes.Drugging the undruggable: targeting challenging E3 ligases for personalized medicine.A novel SHARPIN-PRMT5-H3R2me1 axis is essential for lung cancer cell invasion.MARCH8 is associated with poor prognosis in non-small cell lung cancers patients.The proteasome and proteasome inhibitors in multiple myeloma.E3 ubiquitin ligases in cancer and implications for therapies.Unlocking the NF-κB Conundrum: Embracing Complexity to Achieve Specificity.Knockdown of RNF6 inhibits gastric cancer cell growth by suppressing STAT3 signalingThe role of K63-linked polyubiquitination in cardiac hypertrophy
P2860

Targeting ubiquitination for cancer therapies.

Item
http://www.wikidata.org/entity/Q37158445
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting ubiquitination for cancer therapies.
@en
Targeting ubiquitination for cancer therapies.
@nl
type
label
Targeting ubiquitination for cancer therapies.
@en
Targeting ubiquitination for cancer therapies.
@nl
prefLabel
Targeting ubiquitination for cancer therapies.
@en
Targeting ubiquitination for cancer therapies.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Targeting ubiquitination for cancer therapies
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932